Disease: melanoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma 		0.700 GenomicAlterations disease CGI
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease HPO
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease LHGDN Moreover, suppression of melanoma clonogenic growth by disruption of beta-catenin-T-cell transcription factor/LEF is rescued by constitutive MITF. 12235125 2002
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE These results indicate a role for the MITF-M isoform in the in vivo growth control and the phenotype of human melanoma. 11929831 2002
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease LHGDN Clinically, primary human melanoma expression microarrays revealed tight nearest neighbor linkage for MITF and BCL2. 12086670 2002
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE Clinically, primary human melanoma expression microarrays revealed tight nearest neighbor linkage for MITF and BCL2. 12086670 2002
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. 12235125 2002
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE We also provide evidence that AIM-1 is transcriptionally modulated by MITF, a melanocyte-specific transcription factor essential to pigmentation and a clinical diagnostic marker in human melanoma. 11700328 2002
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. 12819038 2003
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE The second part of the review will briefly discuss the role of other transcription factors, including ATF-2, SNAIL, MITF, and NFkappaB in the progression of human melanoma and will summarize recent knowledge on how changes in the expression of these transcription factors contribute to acquisition of the metastatic phenotype in human melanoma. 12741683 2003
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE Among the SKI targets were microphthalmia-associated transcription factor and Nr-CAM, two proteins associated with melanoma cell survival, growth, motility, and transformation. 14583455 2003
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma. 15577322 2004
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE Collectively, these data indicate that CDK2 activity in melanoma is largely maintained at the transcriptional level by MITF, and unlike other malignancies, it may be a suitable drug target in melanoma. 15607961 2004
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE Similarly, the melanocytic markers MLANA/MART1 and MITF also have been shown to lose relative expression during melanoma progression. 14744763 2004
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE These data suggest that MITF is an anti-proliferation factor that is down-regulated by B-RAF signaling and that this is a crucial event for the progression of melanomas that harbor oncogenic B-RAF. 16129781 2005
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease LHGDN We therefore conclude that the alpha-MSH/cAMP pathway, using MITF as a signal transducer and HIF1alpha as a target, might contribute to melanoma progression. 15983061 2005
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease LHGDN These data suggest that MITF is an anti-proliferation factor that is down-regulated by B-RAF signaling and that this is a crucial event for the progression of melanomas that harbor oncogenic B-RAF. 16129781 2005
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE Targeting MITF in combination with BRAF or cyclin-dependent kinase inhibitors may offer a rational therapeutic avenue into melanoma, a highly chemotherapy-resistant neoplasm. 16001072 2005
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE Through DNA microarray analysis, we found that the antimelanoma effect of IFN-gamma in DM6 was associated with the down-regulation of multiple genes involved in G-protein signaling and phospholipase C activation (including Rap2B and calpain 3) as well as the down-regulation of genes involved in melanocyte/melanoma survival (MITF and SLUG), apoptosis inhibition (Bcl2A1 and galectin-3), and cell cycling (CDK2). 16204058 2005
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE Melanocyte-stimulating hormone-induced expression of MITF protein caused increased sensitivity to 4-TBP, whereas sensitivity of melanomas correlated with MITF expression. 17071589 2006
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE Using an integrated analysis of high-resolution single nucleotide polymorphism maps and gene expression databases associated with the NCI60 collection cancer cell lines, we identified the transcription factor MITF as an amplified oncogene in melanoma that is critical for anchoring lineage dependence and malignant character. 16510564 2006
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease LHGDN By contrast, we show here that in melanomas invasiveness can be regulated epigenetically by the microphthalmia-associated transcription factor, Mitf, via regulation of the DIAPH1 gene encoding the diaphanous-related formin Dia1 that promotes actin polymerization and coordinates the actin cytoskeleton and microtubule networks at the cell periphery. 17182868 2006
CUI: C0025202
Disease: melanoma
melanoma 		0.700 AlteredExpression disease BEFREE We show that EWS-ATF1 occupies the MITF promoter, mimicking melanocyte-stimulating hormone (MSH) signaling to induce expression of MITF, the melanocytic master transcription factor and an amplified oncogene in melanoma. 16766266 2006
CUI: C0025202
Disease: melanoma
melanoma 		0.700 GeneticVariation disease BEFREE For example, MITF (microphthalmia-associated transcription factor), which is a master regulator of the melanocyte lineage, might become a melanoma oncogene when deregulated in certain genetic contexts. 16862190 2006
CUI: C0025202
Disease: melanoma
melanoma 		0.700 Biomarker disease BEFREE It has been demonstrated that MITF is an amplified oncogene in a fraction of human melanomas and that it also has an oncogenic role in human clear cell sarcoma. 16899407 2006